Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart attack delays: new study seeks answers

NCT ID NCT07160556

Knowledge-focused Sponsor: Bacha Khan Medical College Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study looked at 362 adults who had a heart attack to understand why they waited before going to the hospital. Researchers collected information on symptoms, travel time, and other barriers. The goal is to find patterns that can help doctors and communities reduce delays and improve survival.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors identify common reasons for delays in heart attack care, leading to better public education and faster treatment.
What could go wrong
This is an observational study that only looks at past data, so it cannot prove cause and effect. Results may not apply to all hospitals or regions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

362 people

The number who actually took part.

Started

Jul 2024

Finished

Nov 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of adult patients diagnosed with acute myocardial infarction (MI) admitted to the cardiology department. Eligible participants include both male and female patients who meet the clinical and diagnostic criteria for MI and provide informed consent

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years and older with a confirmed diagnosis of myocardial infarction (STEMI or NSTEMI). * Ability to provide informed consent (or consent from a legally authorized representative if patient is incapacitated). Exclusion Criteria: * Severe comorbid illness (e.g., advanced cancer, end-stage renal or liver disease) that may limit survival or affect study outcomes. * Inability to comply with follow-up requirements (e.g., cognitive impairment, lack of contact information, or unwillingness to participate)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DM are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute coronary syndrome cardiovascular disorder diabetes mellitus hypertensive disorder myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DM HTN-hypertension Myocardial infarction

Contacts and locations

Locations

  • Mardan Medical Comlex, Mardan

    Mardan, KPK, 23200, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.